Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Brain and Behavior|February 24, 2022
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studiesKoichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a <i>post-hoc</i> analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Neurology|July 9, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE studyPeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache|December 10, 2019
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% responseJan Lewis Brandes, Hans-Christoph Diener, David Dolezil, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Neurology|December 20, 2019
Vascular safety of erenumab for migraine preventionDavid Kudrow, Julio Pascual, Paul K Winner, et al.
JAMA Neurology|September 16, 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled TrialStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Pageof 6